Skip to main content
    O

    Outset Medical Inc (OM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $3.16
    -0.23 (-6.78%)

    Market Cap: $63.98M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Outset Medical Inc (OM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Outset Medical (OM) has a market cap of $63.98M and an enterprise value of $129.47M. It kept -58.33% of revenue as net income over the last 12 months. Its share count is up 5.89% from a year earlier.

    Total Valuation

    Enterprise value is 102.37% above the market cap, as debt exceeds cash.

    Market Cap$63.98M
    Enterprise Value$129.47M
    Latest price (Nov 17, 2026)$3.16

    Key Dates

    The next earnings report is expected on Jan 11, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateJan 11, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.14% in the quarter ended Sep 30, 2026.

    Shares Outstanding18.83M
    Shares Change (YoY)+5.89%
    Shares Change (QoQ)+1.14%

    Valuation Ratios

    Sales and book value multiples are 0.5x and 0.7x. Its year-end P/S ranged from 0.4x to 20.5x from 2021 to 2025.

    P/S Ratio0.5x
    Forward P/S0.5x
    P/B Ratio0.7x

    Valuation history and multiples

    Price Statistics

    The stock is down 32.48% over 52 weeks and trades 15.73% below its 50-day average.

    Beta (1Y)1.84
    52-Week Change-32.48%
    1-Month Change-16.84%
    3-Month Change-26.51%
    6-Month Change-18.13%
    5-Year Change-99.50%
    Total Return (1Y)-32.48%
    Total Return (3Y CAGR)-65.56%
    Total Return (5Y CAGR)-66.41%
    Return vs SPY (1Y)-47.98%
    Max Drawdown (1Y)-47.89%
    Max Drawdown (3Y)-96.83%
    Sharpe Ratio (1Y)-0.52
    Correlation with SPY (1Y)0.29
    50-Day Average$3.75
    200-Day Average$4.08
    52-Week Range$2.84 to $6.49
    RSI (14 Days)32.5
    Average Volume (20 Days)95.17K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.86x current liabilities, and total debt is 1.19x shareholder equity.

    Current Ratio4.86x
    Quick Ratio3.85x
    Debt / Equity1.19x
    Interest Coverage-4.12x

    Returns and Efficiency

    Return on invested capital is -31.02% over the last 12 months, against a 5-year average of -45.24%.

    Return on Equity (ROE)-85.39%
    Return on Assets (ROA)-30.88%
    Return on Invested Capital (ROIC)-31.02%
    Return on Capital Employed (ROCE)-30.49%
    ROA (5Y Average)-40.31%
    ROIC (5Y Average)-45.24%
    Asset Turnover0.48x
    Inventory Turnover1.53x
    Receivables Turnover4.09x
    Cash Conversion Cycle305 days

    Scores

    OM has an Altman Z-Score of -6.58, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score-6.58
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $121.97M over the last 12 months is up 1.58% from the 12 months before.

    Revenue$121.97M
    Revenue Growth (YoY)+1.58%
    Gross Profit$51.28M
    Operating Income-$62.49M
    Pretax Income-$70.45M
    Net Income-$71.14M
    EBITDA-$55.44M
    EBIT-$56.70M
    Reported EPS (TTM)-$3.38

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 36.16% of the $230.41M in total assets.

    Cash and Equivalents$33.94M
    Total Debt$99.44M
    Net Debt$65.49M
    Net Debt Per Share$3.48
    Working Capital$171.77M
    Shareholder Equity$83.31M
    Book Value Per Share$4.42
    Total Assets$230.41M
    Total Liabilities$147.09M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $508.00K of capital spending, operating cash flow left -$42.89M of free cash flow.

    Operating Cash Flow-$42.38M
    Capital Expenditures$508.00K
    Free Cash Flow-$42.89M
    FCF Per Share-$2.28
    Depreciation and Amortization$4.68M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -51.24%.

    Gross Margin42.04%
    Operating Margin-51.24%
    Pretax Margin-57.76%
    Net Margin-58.33%
    EBITDA Margin-45.45%
    EBIT Margin-46.49%
    FCF Margin-35.16%
    Gross Margin (5Y Average)23.63%

    Growth

    Revenue grew 1.17% a year over 3 years.

    Revenue Growth (3Y CAGR)+1.17%
    Revenue Growth (5Y CAGR)+19.06%

    Revenue and profit by year

    Dividends and Yields

    OM does not pay a dividend. Its free cash flow yield is -72.07%.

    FCF Yield-72.07%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-15 reverse split on Mar 20, 2025.

    Last Split DateMar 20, 2025
    Split TypeReverse split
    Split Ratio1:15

    Peer Position

    Against 12 similar companies, OM has the 12th highest P/S.

    P/S Ratio0.5x vs 1.7x median
    ROIC-31.02% vs -51.95% median
    Revenue Growth (Trailing 4 Quarters, YoY)+1.58% vs +11.06% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 8.20% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+8.20%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OM

    What is OM's market cap?

    Outset Medical has a market cap of $63.98M. Its enterprise value, which adds debt and subtracts cash, is $129.47M.

    How many shares of OM are outstanding?

    Outset Medical has 18.83M shares outstanding. The count is up 5.89% from a year earlier.

    Does OM pay a dividend?

    No. Outset Medical does not pay a dividend.

    How much debt does OM have?

    Outset Medical has $99.44M of total debt and $33.94M of cash and equivalents, a net debt position of $65.49M.